Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
15
TMCI Quote, Financials, Valuation and Earnings
Last price:
$2.75
Seasonality move
:
14.54%
Day range:
$2.63 - $2.78
52-week range:
$2.56 - $10.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.79x
P/B ratio:
1.96x
Volume:
613.8K
Avg. volume:
943.7K
1-year change:
-64.65%
Market cap:
$174.6M
Revenue:
$209.4M
EPS (TTM):
-$0.79
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
TMCI
Treace Medical Concepts, Inc.
|
$49.7M | -$0.27 | -10.11% | -1650% | $6.56 |
|
CATX
Perspective Therapeutics, Inc.
|
$206.8K | -$0.32 | -9.65% | -37.91% | $12.3077 |
|
PMI
Picard Medical
|
-- | -- | -- | -- | -- |
|
VNRX
VolitionRX Ltd.
|
$806.3K | -$0.04 | 272.5% | -33.67% | $2.60 |
|
VTAK
Catheter Precision, Inc.
|
$310K | -$0.20 | 118.75% | -11.57% | -- |
|
XTNT
Xtant Medical Holdings, Inc.
|
$28.5M | -- | 2.34% | -100% | $1.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
TMCI
Treace Medical Concepts, Inc.
|
$2.74 | $6.56 | $174.6M | -- | $0.00 | 0% | 0.79x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.4000 | $12.3077 | $178.4M | -- | $0.00 | 0% | 162.73x |
|
PMI
Picard Medical
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
VNRX
VolitionRX Ltd.
|
$0.30 | $2.60 | $36.8M | -- | $0.00 | 0% | 20.54x |
|
VTAK
Catheter Precision, Inc.
|
$2.38 | -- | $2.9M | 0.40x | $0.00 | 0% | 11.19x |
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.62 | $1.50 | $86.2M | 60.39x | $0.00 | 0% | 0.67x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
TMCI
Treace Medical Concepts, Inc.
|
44.1% | 1.305 | 16.46% | 2.25x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.691 | 1.3% | 8.47x |
|
PMI
Picard Medical
|
-- | 0.000 | -- | -- |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.566 | 15.4% | 0.04x |
|
VTAK
Catheter Precision, Inc.
|
68.63% | -0.348 | 537.37% | 0.41x |
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 2.955 | 35.76% | 1.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
TMCI
Treace Medical Concepts, Inc.
|
$39.7M | -$15.7M | -29.15% | -49.13% | -31.22% | -$11.9M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
PMI
Picard Medical
|
-- | -- | -- | -- | -- | -- |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
VTAK
Catheter Precision, Inc.
|
-$320K | -$3M | -79.27% | -192.05% | -1336.73% | -$2.2M |
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
Treace Medical Concepts, Inc. vs. Competitors
-
Which has Higher Returns TMCI or CATX?
Perspective Therapeutics, Inc. has a net margin of -32.44% compared to Treace Medical Concepts, Inc.'s net margin of -12425.36%. Treace Medical Concepts, Inc.'s return on equity of -49.13% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital TMCITreace Medical Concepts, Inc.79.07% -$0.26 $159.6M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About TMCI or CATX?
Treace Medical Concepts, Inc. has a consensus price target of $6.56, signalling upside risk potential of 99.64%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 412.82%. Given that Perspective Therapeutics, Inc. has higher upside potential than Treace Medical Concepts, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than Treace Medical Concepts, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TMCITreace Medical Concepts, Inc.2 3 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is TMCI or CATX More Risky?
Treace Medical Concepts, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.222, suggesting its more volatile than the S&P 500 by 22.249%.
-
Which is a Better Dividend Stock TMCI or CATX?
Treace Medical Concepts, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Treace Medical Concepts, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMCI or CATX?
Treace Medical Concepts, Inc. quarterly revenues are $50.2M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. Treace Medical Concepts, Inc.'s net income of -$16.3M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Treace Medical Concepts, Inc.'s price-to-earnings ratio is -- while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Treace Medical Concepts, Inc. is 0.79x versus 162.73x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMCITreace Medical Concepts, Inc.0.79x -- $50.2M -$16.3M CATXPerspective Therapeutics, Inc.162.73x -- $209K -$26M
-
Which has Higher Returns TMCI or PMI?
Picard Medical has a net margin of -32.44% compared to Treace Medical Concepts, Inc.'s net margin of --. Treace Medical Concepts, Inc.'s return on equity of -49.13% beat Picard Medical's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TMCITreace Medical Concepts, Inc.79.07% -$0.26 $159.6M PMIPicard Medical-- -- -- -
What do Analysts Say About TMCI or PMI?
Treace Medical Concepts, Inc. has a consensus price target of $6.56, signalling upside risk potential of 99.64%. On the other hand Picard Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that Treace Medical Concepts, Inc. has higher upside potential than Picard Medical, analysts believe Treace Medical Concepts, Inc. is more attractive than Picard Medical.
Company Buy Ratings Hold Ratings Sell Ratings TMCITreace Medical Concepts, Inc.2 3 0 PMIPicard Medical0 0 0 -
Is TMCI or PMI More Risky?
Treace Medical Concepts, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Picard Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock TMCI or PMI?
Treace Medical Concepts, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Picard Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Treace Medical Concepts, Inc. pays -- of its earnings as a dividend. Picard Medical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMCI or PMI?
Treace Medical Concepts, Inc. quarterly revenues are $50.2M, which are larger than Picard Medical quarterly revenues of --. Treace Medical Concepts, Inc.'s net income of -$16.3M is higher than Picard Medical's net income of --. Notably, Treace Medical Concepts, Inc.'s price-to-earnings ratio is -- while Picard Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Treace Medical Concepts, Inc. is 0.79x versus -- for Picard Medical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMCITreace Medical Concepts, Inc.0.79x -- $50.2M -$16.3M PMIPicard Medical-- -- -- --
-
Which has Higher Returns TMCI or VNRX?
VolitionRX Ltd. has a net margin of -32.44% compared to Treace Medical Concepts, Inc.'s net margin of -862.39%. Treace Medical Concepts, Inc.'s return on equity of -49.13% beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TMCITreace Medical Concepts, Inc.79.07% -$0.26 $159.6M VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About TMCI or VNRX?
Treace Medical Concepts, Inc. has a consensus price target of $6.56, signalling upside risk potential of 99.64%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.60 which suggests that it could grow by 767.53%. Given that VolitionRX Ltd. has higher upside potential than Treace Medical Concepts, Inc., analysts believe VolitionRX Ltd. is more attractive than Treace Medical Concepts, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TMCITreace Medical Concepts, Inc.2 3 0 VNRXVolitionRX Ltd.4 2 0 -
Is TMCI or VNRX More Risky?
Treace Medical Concepts, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.
-
Which is a Better Dividend Stock TMCI or VNRX?
Treace Medical Concepts, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Treace Medical Concepts, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMCI or VNRX?
Treace Medical Concepts, Inc. quarterly revenues are $50.2M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Treace Medical Concepts, Inc.'s net income of -$16.3M is lower than VolitionRX Ltd.'s net income of -$5.4M. Notably, Treace Medical Concepts, Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Treace Medical Concepts, Inc. is 0.79x versus 20.54x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMCITreace Medical Concepts, Inc.0.79x -- $50.2M -$16.3M VNRXVolitionRX Ltd.20.54x -- $627.3K -$5.4M
-
Which has Higher Returns TMCI or VTAK?
Catheter Precision, Inc. has a net margin of -32.44% compared to Treace Medical Concepts, Inc.'s net margin of -1037.17%. Treace Medical Concepts, Inc.'s return on equity of -49.13% beat Catheter Precision, Inc.'s return on equity of -192.05%.
Company Gross Margin Earnings Per Share Invested Capital TMCITreace Medical Concepts, Inc.79.07% -$0.26 $159.6M VTAKCatheter Precision, Inc.-141.59% -$1.70 $21.3M -
What do Analysts Say About TMCI or VTAK?
Treace Medical Concepts, Inc. has a consensus price target of $6.56, signalling upside risk potential of 99.64%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1496.69%. Given that Catheter Precision, Inc. has higher upside potential than Treace Medical Concepts, Inc., analysts believe Catheter Precision, Inc. is more attractive than Treace Medical Concepts, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TMCITreace Medical Concepts, Inc.2 3 0 VTAKCatheter Precision, Inc.0 0 0 -
Is TMCI or VTAK More Risky?
Treace Medical Concepts, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.
-
Which is a Better Dividend Stock TMCI or VTAK?
Treace Medical Concepts, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Treace Medical Concepts, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMCI or VTAK?
Treace Medical Concepts, Inc. quarterly revenues are $50.2M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Treace Medical Concepts, Inc.'s net income of -$16.3M is lower than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Treace Medical Concepts, Inc.'s price-to-earnings ratio is -- while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Treace Medical Concepts, Inc. is 0.79x versus 11.19x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMCITreace Medical Concepts, Inc.0.79x -- $50.2M -$16.3M VTAKCatheter Precision, Inc.11.19x 0.40x $226K -$2.3M
-
Which has Higher Returns TMCI or XTNT?
Xtant Medical Holdings, Inc. has a net margin of -32.44% compared to Treace Medical Concepts, Inc.'s net margin of 3.93%. Treace Medical Concepts, Inc.'s return on equity of -49.13% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.
Company Gross Margin Earnings Per Share Invested Capital TMCITreace Medical Concepts, Inc.79.07% -$0.26 $159.6M XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M -
What do Analysts Say About TMCI or XTNT?
Treace Medical Concepts, Inc. has a consensus price target of $6.56, signalling upside risk potential of 99.64%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 143.51%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Treace Medical Concepts, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than Treace Medical Concepts, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TMCITreace Medical Concepts, Inc.2 3 0 XTNTXtant Medical Holdings, Inc.2 0 0 -
Is TMCI or XTNT More Risky?
Treace Medical Concepts, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.
-
Which is a Better Dividend Stock TMCI or XTNT?
Treace Medical Concepts, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Treace Medical Concepts, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMCI or XTNT?
Treace Medical Concepts, Inc. quarterly revenues are $50.2M, which are larger than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Treace Medical Concepts, Inc.'s net income of -$16.3M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Treace Medical Concepts, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 60.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Treace Medical Concepts, Inc. is 0.79x versus 0.67x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMCITreace Medical Concepts, Inc.0.79x -- $50.2M -$16.3M XTNTXtant Medical Holdings, Inc.0.67x 60.39x $33.3M $1.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
